NCT02234297View on ClinicalTrials.gov

Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

March 31, 2016

Conditions
Glioma
Interventions
DRUG

BLZ-100

Trial Locations (2)

90048

Cedars-Sinai Medical Center, Los Angeles

Auchenflower

NEWRO Foundation, Brisbane

Sponsors
All Listed Sponsors
lead

Blaze Bioscience Inc.

INDUSTRY